Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
- 10 more years available »
Ranking
By Turnover
(€13.7 billion)- 11th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €13.7 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 8:30pm Former leading tourism figure Eileen O’Mara Walsh dies aged 79
- 11:10am Apple buys Irish voice tech company Voysis to help improve Siri
- 5:55am Cash-starved workers should get access to pension funds, says Mercer
- 5:16am CRH chief’s €9.3m pay package under scrutiny as Covid-19 impacts earnings
- 4:00am Debt market freeze hits sour note for Bank of Ireland